25 May 2013
Keywords: safinamide, raises, time, hrs, ph, iii, trial
Article | 09 February 2009
Italy's Newron Pharmaceuticals SpA and its partner, German drugmaker Merck Serono, says that the first Phase III trial of safinamide ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 February 2009
16 February 2009
24 May 2013
© 2013 thepharmaletter.com